Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

750
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
750
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

476
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
476
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

572
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
572
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

324
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
324
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Sex-Specific Growth Rates of Ascending Thoracic Aortic Aneurysms in Non-Syndromic Patients: A Systematic Review.

Diagnostics (Basel, Switzerland)·2026
Same author

Big data, blunt tools: What national registries still miss in aortic dissection.

Progress in cardiovascular diseases·2026
Same author

Evolving dynamic needs for patient-reported outcomes assessment in individuals with an abdominal aortic aneurysm (AAA): A systematic review.

Vascular medicine (London, England)·2026
Same author

Aortic and Iliac Calcifications as Predictors of Aortic Dissection, Aneurysm Rupture, and Peripheral Vascular Disease: A Prospective Cohort Study from the DANCAVAS Trials.

Circulation·2026
Same author

IGF-PAPP-A-stanniocalcin axis and androgenic anabolic steroid use in men and women.

European journal of endocrinology·2026
Same author

We all risk misrepresenting the results from the DANCAVAS trials.

European heart journal·2026

関連する実験動画

Updated: Feb 23, 2026

Non-invasive Assessment of Microvascular and Endothelial Function
05:41

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

16.7K

デンマークの男性における血管疾患の集団スクリーニングと介入 (VIVA):ランダム化制御試験

Jes S Lindholt1, Rikke Søgaard2

  • 1Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark; Vascular Research Unit, Viborg Hospital, Viborg, Denmark.

Lancet (London, England)
|September 2, 2017
PubMed
まとめ
この要約は機械生成です。

腹動脈動脈瘤,外周動脈疾患,高血圧の併用スクリーニングにより,全因死亡率が著しく低下しました. このアプローチは主に薬剤療法によるもので 住民の健康を改善するための新しい戦略です

さらに関連する動画

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

16.9K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.0K

関連する実験動画

Last Updated: Feb 23, 2026

Non-invasive Assessment of Microvascular and Endothelial Function
05:41

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

16.7K
A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

16.9K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.0K

科学分野:

  • 心血管疾患の研究
  • 公衆衛生スクリーニングプログラム
  • 臨床試験の方法論

背景:

  • 腹動脈動脈瘤は,集団スクリーニングの対象となる唯一の心血管疾患です.
  • この研究では,腹動脈動脈瘤,外周動脈疾患,高血圧のスクリーニングと介入の組み合わせによる影響を調査しています.

研究 の 目的:

  • 腹動脈動脈瘤,外周動脈疾患,高血圧の統合スクリーニングプログラムの有効性を評価する.
  • すべての原因による死亡率に対するこの統合スクリーニングの影響を評価する.

主な方法:

  • ランダム化比較試験では,65歳から74歳の男性をスクリーニングまたはスクリーニングなしに分けました.
  • 主なアウトカムは,ランダム化から5年後に評価された全因死亡率でした.
  • 特定された状態の参加者は,確認,治療開始,または紹介を受けた.

主要な成果:

  • 合計で50,156人の参加者がランダムに割り当てられました.
  • スクリーニンググループでは,あらゆる原因による死亡率が有意に減少した (HR 0. 93, p=0. 01).
  • 糖尿病,脳内出血,腎不全,癌,または手術後の30日間の死亡率において,有意な違いは認められなかった.

結論:

  • これらの血管疾患を組み合わせたスクリーニングは,死亡リスクを有意に低下させる.
  • 観察された効果は,主に薬理学的治療の開始によるものです.
  • 保健政策は,この統合されたスクリーニングアプローチの実施を検討すべきです.